FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Dobutamine Hydrochloride Injection

  • U.S. Food and Drug Administration
  • August 24, 2026
  • ID: shortage-dobutamine-hydrochloride-injection-hospira-inc-a-pfizer-company-0409-2344-02

Drug Shortage Details

Generic NameDobutamine Hydrochloride Injection
Manufacturer / CompanyHospira, Inc., a Pfizer Company
Therapeutic CategoryCardiovascular, Pediatric, Renal
Availability StatusAvailable
Status (FDA list)Current
NDC Package Code0409-2344-02
Presentation & Dosage Form

Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02)

Manufacturer Contact Info

844-646-4398


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.